Sign up to save your podcasts
Or
Share SGLT2 Inhibitors vs. GLP-1 RAs in Diabetes, MRI Lesions After TAVR, Perioperative Management and Anticoagulants
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
SGLT2 Inhibitors vs. GLP-1 RAs in Diabetes, MRI Lesions After TAVR, Perioperative Management and Anticoagulants
In this week’s View, Dr. Eagle looks at the kidney and cardiovascular effectiveness of SGLT2 inhibitors versus GLP-1 receptor agonists in type 2 diabetes. He then explores the prognostic ability of diffusion-weighted brain MRI lesions after TAVR. Finally, Dr. Eagle discusses perioperative management of patients taking direct oral anticoagulants, particularly those being considered for noncardiac surgery.
Subscribe to Eagle’s Eye View
View all episodes
By American College of Cardiology
4.7
128128 ratings
In this week’s View, Dr. Eagle looks at the kidney and cardiovascular effectiveness of SGLT2 inhibitors versus GLP-1 receptor agonists in type 2 diabetes. He then explores the prognostic ability of diffusion-weighted brain MRI lesions after TAVR. Finally, Dr. Eagle discusses perioperative management of patients taking direct oral anticoagulants, particularly those being considered for noncardiac surgery.
Subscribe to Eagle’s Eye View
More shows like Eagle's Eye View: Your Weekly CV Update From ACC.org
View all
JAMA Editors' Summary
139 Listeners
NEJM This Week
322 Listeners
JACC This Week
170 Listeners
This Week in Cardiology
872 Listeners
JAMA Clinical Reviews
502 Listeners
Circulation on the Run
31 Listeners
Mayo Clinic Talks
282 Listeners
The Curbsiders Internal Medicine Podcast
3,333 Listeners
Core IM | Internal Medicine Podcast
1,111 Listeners
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
60 Listeners
ACC CardiaCast
38 Listeners
Annals On Call Podcast
195 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
350 Listeners
Cardionerds: A Cardiology Podcast
424 Listeners
Mayo Clinic Cardiovascular CME
38 Listeners